Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

3,672 public trials 794 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer

NCT00003072

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, +31 more
Locations
  • Oncology Service of San Francisco General Hospital Medical Center San Francisco, California, United States
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
  • UCSF/Mt. Zion Cancer Center San Francisco, California, United States
  • Veterans Affairs Medical Center - San Francisco San Francisco, California, United States
View Trial Details
Completed

Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug

NCT00988936

Conditions
Breast Diseases, Breast Neoplasms, Colonic Diseases, +22 more
Locations
  • University of California, Irvine Irvine, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • UMDNJ Newark, New Jersey, United States
  • Beth Israel Medical Center New York, United States
View Trial Details
Completed

Gemcitabine With or Without CI-994 in Treating Patients With Advanced Non-small Cell Lung Cancer

NCT00005093

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Cedars-Sinai Comprehensive Cancer Center Los Angeles, California, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • New England Medical Center Hospital Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View all 16 locations
View Trial Details
Completed

Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC

NCT00294762

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Central Hematology Oncology Medical Group Inc. Alhambra, California, United States
  • Comprehensive Blood and Cancer Center(Part of TORI network) Bakersfield, California, United States
  • Bay Area Cancer Research Group Concord, California, United States
  • Virginia K. Crosson Cancer Center Fullerton, California, United States
View all 43 locations
View Trial Details

Related conditions